INTERSTITIAL LUNG DISEASES
Clinical trials for INTERSTITIAL LUNG DISEASES explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASES trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for scarred lungs: new pill may slow breathing decline
Disease control Not yet recruitingThis study tests a pill called nerandomilast in adults with fibrosing interstitial lung disease (lung scarring) who are at risk of worsening. About 466 participants will receive either the drug or a placebo for at least 52 weeks. The goal is to see if nerandomilast can slow the d…
Matched conditions: INTERSTITIAL LUNG DISEASES
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Lung wash test could unlock better diagnosis for scarred lungs
Knowledge-focused Not yet recruitingThis study looks at how analyzing fluid from the lungs (bronchoalveolar lavage) can help doctors tell apart different types of interstitial lung diseases, a group of conditions that cause lung scarring and breathing problems. Researchers will study 66 adults suspected of having t…
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: Maha Ahmed Abd EL Gawad Mohammed Okasha • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC